Ifp Advisors, Inc Novo Nordisk A S Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Ifp Advisors, Inc holds 11,966 shares of NVO stock, worth $1.06 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

11,966

Previous 10,782 10.98%

Holding current value

$1.06 Million

Previous $1.38 Million 23.41%

% of portfolio

0.07%

Previous 0.06%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$122.71 - $146.91 $145,288 - $173,941	1,184 Added 10.98%	11,966 $1.71 Million
Q1 2024 Jul 30, 2024	BUY	$102.11 - $135.92 $471,339 - $627,406	4,616 Added 74.86%	10,782 $1.38 Million
Q4 2023 Jan 09, 2024	BUY	$87.78 - $105.45 $168,713 - $202,674	1,922 Added 45.29%	6,166 $637,000
Q3 2023 Oct 12, 2023	BUY	$90.94 - $199.54 $147,140 - $322,855	1,618 Added 61.61%	4,244 $385,000
Q2 2023 Aug 04, 2023	SELL	$155.98 - $172.65 $3,587 - $3,970	-23 Reduced 0.87%	2,626 $424,000
Q1 2023 Apr 18, 2023	SELL	$132.34 - $159.14 $190,569 - $229,161	-1,440 Reduced 35.22%	2,649 $421,000
Q4 2022 Feb 07, 2023	SELL	$102.55 - $135.33 $63,478 - $83,769	-619 Reduced 13.15%	4,089 $202,000
Q3 2022 Nov 08, 2022	BUY	$95.28 - $116.93 $54,595 - $67,000	573 Added 13.86%	4,708 $235,000
Q2 2022 Sep 06, 2022	BUY	$103.24 - $121.81 $426,897 - $503,684	4,135 New	4,135 $207,000
Q2 2022 Aug 12, 2022	SELL	$103.24 - $121.81 $426,897 - $503,684	-4,135 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$93.1 - $112.54 $219,529 - $265,369	2,358 Added 132.7%	4,135 $459,000
Q1 2022 Aug 08, 2022	BUY	$93.1 - $112.54 $94,962 - $114,790	1,020 Added 134.74%	1,777 $197,000
Q4 2021 Jan 12, 2022	SELL	$95.88 - $117.08 $51,775 - $63,223	-540 Reduced 41.63%	757 $86,000
Q3 2021 Oct 06, 2021	BUY	$84.42 - $106.62 $34,865 - $44,034	413 Added 46.72%	1,297 $125,000
Q2 2021 Jul 13, 2021	SELL	$67.66 - $84.76 $2,841 - $3,559	-42 Reduced 4.54%	884 $75,000
Q1 2021 Apr 30, 2021	SELL	$67.06 - $75.82 $13,747 - $15,543	-205 Reduced 18.13%	926 $62,000
Q4 2020 Jan 25, 2021	SELL	$63.89 - $73.8 $32,903 - $38,007	-515 Reduced 31.29%	1,131 $79,000
Q3 2020 Oct 29, 2020	BUY	$63.69 - $70.22 $56,811 - $62,636	892 Added 118.3%	1,646 $115,000
Q2 2020 Aug 05, 2020	SELL	$58.54 - $67.94 $23,942 - $27,787	-409 Reduced 35.17%	754 $50,000
Q1 2020 May 12, 2020	SELL	$49.46 - $64.78 $4,253 - $5,571	-86 Reduced 6.89%	1,163 $66,000
Q4 2019 Jan 17, 2020	BUY	$49.86 - $58.26 $3,041 - $3,553	61 Added 5.13%	1,249 $73,000
Q3 2019 Nov 07, 2019	SELL	$47.54 - $53.43 $16,639 - $18,700	-350 Reduced 22.76%	1,188 $61,000
Q1 2019 May 15, 2019	SELL	$46.36 - $52.63 $109,595 - $124,417	-2,364 Reduced 60.58%	1,538 $79,000
Q4 2018 Jan 23, 2019	SELL	$41.54 - $47.25 $14,040 - $15,970	-338 Reduced 7.97%	3,902 $179,000
Q3 2018 Oct 25, 2018	BUY	$46.76 - $51.24 $7,388 - $8,095	158 Added 3.87%	4,240 $0
Q2 2018 Aug 07, 2018	SELL	$44.29 - $50.42 $294,129 - $334,839	-6,641 Reduced 61.93%	4,082 $0
Q1 2018 Jun 03, 2019	BUY	$48.49 - $58.14 $331,041 - $396,921	6,827 Added 175.23%	10,723 $576,000
Q1 2018 May 09, 2018	SELL	$48.49 - $58.14 $331,041 - $396,921	-6,827 Reduced 63.67%	3,896 $0
Q4 2017 Jan 24, 2018	BUY	$47.53 - $53.73 $24,810 - $28,047	522 Added 5.12%	10,723 $0
Q3 2017 Oct 30, 2017	BUY	$41.15 - $49.22 $12,838 - $15,356	312 Added 3.16%	10,201 $491,000
Q2 2017 Jun 03, 2019	SELL	N/A	-708 Reduced 6.68%	9,889 $424,000
Q1 2017 Jun 03, 2019	SELL	N/A	-182 Reduced 1.69%	10,597 $363,000
Q4 2016 Jun 03, 2019	SELL	N/A	-3,440 Reduced 24.19%	10,779 $387,000
Q2 2016 Jun 03, 2019	BUY	N/A	12,681 Added 824.51%	14,219 $765,000
Q1 2016 Jun 03, 2019	BUY	N/A	1,538	1,538 $79,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $200B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account